Jul 23, 2026 04:05PM
Jul 23, 2026 04:05PM
Jun 22, 2026 08:02AM
Jun 22, 2026 08:00AM
May 7, 2026 08:00AM
Mar 4, 2026 04:51AM
Mar 3, 2026 08:00AM Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Nov 7, 2025 10:21AM
Nov 7, 2025 07:00AM
Aug 7, 2025 08:00AM
Jul 21, 2025 04:12AM
May 19, 2025 08:32AM
May 19, 2025 08:31AM
May 19, 2025 08:30AM Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
Jan 6, 2025 10:35AM
Sep 30, 2024 07:05AM
Sep 30, 2024 07:01AM
Aug 8, 2024 08:00AM
May 16, 2024 05:10AM
May 10, 2024 08:00AM
May 8, 2024 08:01AM Prime Medicine (PRME) Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease
May 8, 2024 08:00AM
Apr 29, 2024 07:05AM
Apr 29, 2024 07:01AM
Apr 29, 2024 07:00AM
Mar 1, 2024 08:00AM
Nov 3, 2023 04:01PM
Apr 17, 2023 04:08PM Stifel Starts Prime Medicine (PRME) at Buy

326,502 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All